Hyperbaric oxygen therapy (HBOT) is the use of oxygen at increased atmospheric pressure. It is a non-invasive, painless procedure that improves the body's natural healing process. The patient inhales 100% oxygen in a total body chamber where atmospheric pressure is increased and controlled. Today, patients are treated in either monoplace chambers or multiplace chambers.
Physicians learn at the bedside through “teaching moments” encountered when interacting with patients. The majority of the available products do not replicate this approach. A conventional textbook is formatted in a hierarchical and linear fashion, and newer web-based resources are informative and non-hierarchical but do not address information in a practical, patient-focused approach. The optimal way to learn is to see the aspects of management demonstrated in a clinical context. Hence, the approach of this text will use case presentations, which are illustrative of key management principles. Additionally, principles of management can be divided into conventional management and into aspects of care which are more controversial.
Written by experts in the field, Evidence-Based Hyperbaric Medicine provides evidence-based, practical, helpful information for anyone involved in Hyperbaric Oxygen Therapy. It covers the physiologic principles that constitute the basis for understanding the basic principles, clinical implications and treatment applications. Different applications of HBOT are discussed as well as recent advances, research and new therapeutic approaches.
Chapter
1. History of Hyperbaric and Diving Medicine.
Chapter
2.
Physical and physiological aspects of hyperbaric oxygen therapy.
Chapter
3.
Toxic Effect of Hyerbaric Breathing Gas Mixture.
Chapter
4. Cardiovascular
Changes during Hyperbaric Oxygen Therapy.-Chapter
5. Hyperbaric Oxygen
Therapy in pregnancy.
Chapter
6. Safety in Hyperbaric Medicine.
Chapter
7.
Evidence-Based Hyperbaric Medicine: Concepts and Clinical Application.-
Chapter
8. Hyperbaric Oxygen Therapy in the Management of Gas Embolism.-
Chapter
9. Recommended Indications: Carbon Monoxide Poisioning.
Chapter
10.
Hyperbaric Oxygen Therapy in Necrotizing Soft Tissue Infections.
Chapter
11.
Refractory Osteomyelitis.
Chapter
12. Hyperbaric Oxygen Therapy and Burns.-
Chapter
13. Hyperbaric Oxygen Therapy for Hearing Loss.
Chapter
14.
Hyperbaric Oxygen Therapy (HBOT) in Diabetes Mellitus.
Chapter
15. Diabetic
and Ischemic Wound.-Chapter
16. Hyperbaric Oxgyen Therapy for Diabetic Foot
Ulcers.
Chapter
17. Compromised Grafts and Flaps.
Chapter
18. Recommended
Indications - Intracranial Abcess.
Chapter
19. Hyperbaric Medicine in
Critical Care.
Chapter
20. Clinical Evaluation of Patients Proposed to
Hyperbaric Oxygen Therapy and Contraindications.
Chapter
21. The Effect of
High Pressures on Human Body Physiology.
Chapter
22. Hyperbaric Oxygen
Therapy (HBOT): Role of Pressure.
Chapter
23. Complications of Hyperbaric
Oxygen Therapy - Oxygen toxicity.
Dr. Antonio Joao Gandra DAlmeida is a doctor in the Portuguese Armed Forces, with areas of interest in general surgery, critical care patients and catastrophe. He has a European Masters in Catastrophe, is a Fellow of the Society of Critical Care Medicine, a Fellow of the American College of Surgeons, a Trainer of several courses in his areas of interest and an Editor of FCCS Surgical who has collaborated on several books.
Dr. Jorge Hidalgo is a Professor of Critical Care and Head of the Division of Critical Care at Belize Healthcare Partners. He currently serves as President of the World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM).
In 2012, Dr. Hidalgo was awarded the Master of the American College of Physicians (MACP), the highest recognition the College bestows upon its members. For over a decade, he has been the Director of the prestigious ACP Review Course hosted by the Paraguayan Society of Internal Medicine.
In recognition of his outstanding contributions to the Society of Critical Care Medicine (SCCM), Dr. Hidalgo has received the Presidential Citation Award for ten consecutive years. He is also a two-time recipient (2016 and 2023) of the Global Safar Award, and in 2016 became the first Latin American intensivist to receive the title Master of the American College of Critical Care Medicine (MACCCM).
A Fellow of the American College of Chest Physicians (FCCP), Dr. Hidalgo is an accomplished author and editor of numerous books and chapters on Critical Care Medicine. His recent publications with Springer include Critical Care Administration and Highly Infectious Diseases in Critical Care. He serves as Editor of Fundamental Critical Care Support (FCCS) Tropical and actively contributes to the review and development of the MCCRC, FCCS, FCCS Obstetrics, and FCCS Surgical courses for the SCCM.
Dr. Hidalgo is the SCCM Co-Chair of the Surviving Sepsis Campaign for Low-Resource Settings and is a regular international speaker, sharing his expertise and advancing critical care globally.
